ALIGN TECHNOLOGY, INC. Deferred Revenue Recognized
ALIGN TECHNOLOGY, INC. (ALGN) reported Deferred Revenue Recognized of $234.30 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Income Statement › Other Income
us-gaap:ContractWithCustomerLiabilityRevenueRecognized · last filed 2026-08-05
- ALIGN TECHNOLOGY, INC. contract with customer, liability, revenue recognized for the quarter ending 2026-06-30 was $234.30M, a 2.14% increase year-over-year.
- ALIGN TECHNOLOGY, INC. contract with customer, liability, revenue recognized for the quarter ending 2026-03-31 was $246.40M, a 0.16% increase year-over-year.
- ALIGN TECHNOLOGY, INC. contract with customer, liability, revenue recognized for the quarter ending 2025-09-30 was $200.00M, a 0.50% increase year-over-year.
- ALIGN TECHNOLOGY, INC. contract with customer, liability, revenue recognized for the quarter ending 2025-06-30 was $229.40M, a 3.15% increase year-over-year.
- ALIGN TECHNOLOGY, INC. contract with customer, liability, revenue recognized for fiscal 2025 was $840.50M, a 2.63% increase from fiscal 2024.
- ALIGN TECHNOLOGY, INC. contract with customer, liability, revenue recognized for fiscal 2024 was $819.00M, a 11.82% increase from fiscal 2023.
- ALIGN TECHNOLOGY, INC. contract with customer, liability, revenue recognized for fiscal 2023 was $732.40M, a 15.28% increase from fiscal 2022.
- ALIGN TECHNOLOGY, INC. contract with customer, liability, revenue recognized for fiscal 2022 was $635.30M, a 32.05% increase from fiscal 2021.
| Period end | Contract with Customer, Liability, Revenue Recognized | Contract with Customer, Liability, Revenue Recognized 3 month | Contract with Customer, Liability, Revenue Recognized 3 month as first filed | Contract with Customer, Liability, Revenue Recognized 6 month | Contract with Customer, Liability, Revenue Recognized 9 month | Contract with Customer, Liability, Revenue Recognized 9 month as first filed | Contract with Customer, Liability, Revenue Recognized 12 month |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | $234.30M 10-Q · filed 2026-08-05 | $480.70M 10-Q · filed 2026-08-05 | |||||
| 2026-03-31 | $246.40M 10-Q · filed 2026-05-06 | ||||||
| 2025-12-31 | $840.50M 10-K · filed 2026-02-27 | ||||||
| 2025-09-30 | $200.00M 10-Q · filed 2025-11-05 | $675.30M 10-Q · filed 2025-11-05 | |||||
| 2025-06-30 | $229.40M 10-Q · filed 2026-08-05 | $475.40M 10-Q · filed 2026-08-05 | |||||
| 2025-03-31 | $246.00M 10-Q · filed 2026-05-06 | ||||||
| 2024-12-31 | $819.00M 10-K · filed 2026-02-27 | ||||||
| 2024-09-30 | $199.00M 10-Q · filed 2025-11-05 | $658.20M 10-Q · filed 2025-11-05 | |||||
| 2024-06-30 | $222.40M 10-Q · filed 2025-08-06 | $459.20M 10-Q · filed 2025-08-06 | |||||
| 2024-03-31 | $236.80M 10-Q · filed 2025-05-08 | ||||||
| 2023-12-31 | $732.40M 10-K · filed 2025-02-28 | ||||||
| 2023-09-30 | $178.80M 10-Q · filed 2024-11-05 | $583.50M 10-Q · filed 2024-11-05 | |||||
| 2023-06-30 | $199.00M 10-Q · filed 2024-08-02 | $404.70M 10-Q · filed 2024-08-02 | |||||
| 2023-03-31 | $205.70M 10-Q · filed 2024-05-03 | ||||||
| 2022-12-31 | $635.30M 10-K · filed 2024-02-28 | ||||||
| 2022-09-30 | $156.50M 10-Q · filed 2023-11-03 | $519.80M 10-Q · filed 2023-11-03 | |||||
| 2022-06-30 | $178.40M 10-Q · filed 2023-08-04 | $363.30M 10-Q · filed 2023-08-04 | |||||
| 2022-03-31 | $184.90M 10-Q · filed 2023-05-05 | ||||||
| 2021-12-31 | $481.10M 10-K · filed 2023-02-27 | ||||||
| 2021-09-30 | $122.20M 10-Q · filed 2022-11-04 | $112.60M 10-Q · filed 2021-11-02 | $382.40M 10-Q · filed 2022-11-04 | $349.70M 10-Q · filed 2021-11-02 | |||
| 2021-06-30 | $134.40M 10-Q · filed 2022-08-04 | $260.20M 10-Q · filed 2022-08-04 | |||||
| 2021-03-31 | $125.80M 10-Q · filed 2022-05-05 | ||||||
| 2020-12-31 | $341.90M 10-K · filed 2022-02-25 | ||||||
| 2020-09-30 | $99.60M 10-Q · filed 2021-11-02 | $263.30M 10-Q · filed 2021-11-02 | |||||
| 2020-06-30 | $72.40M 10-Q · filed 2021-08-04 | $167.90M 10-Q · filed 2021-08-04 | |||||
| 2020-03-31 | $95.50M 10-Q · filed 2021-05-05 | ||||||
| 2019-12-31 | $262.70M 10-K · filed 2021-02-26 | ||||||
| 2019-09-30 | $70.10M 10-Q · filed 2020-10-30 | $207.00M 10-Q · filed 2020-10-30 | |||||
| 2018-12-31 | $68.60M 10-Q · filed 2019-08-01 | $180.60M 10-K · filed 2020-02-28 | |||||
| 2017-12-31 | $52.60M 10-Q · filed 2019-08-01 | $119.00M 10-K · filed 2019-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MSA Safety Inc (MSA) | United States | $7.023B | 21.47 |
| ZIMMER BIOMET HOLDINGS, INC. (ZBH) | United States | $17.103B | 20.66 |
| ESTABLISHMENT LABS HOLDINGS INC. (ESTA) | $1.954B | -65.76 | |
| Cadre Holdings, Inc. (CDRE) | United States | $1.123B | 33.88 |
| Enovis CORP (ENOV) | United States | $1.053B | -1.18 |
| Anteris Technologies Global Corp. (AVR) | United States | $0.746B | |
| STERIS plc (STE) | Ireland | $20.343B | 25.49 |
| Sanara MedTech Inc. (SMTI) | United States | $0.323B | -6.81 |
| Inogen Inc (INGN) | United States | $0.139B | -7.00 |
| Conexeu Sciences Inc. (CNXU) | United States | $0.111B |